Nokayun

HealthcareAngelShanghai, Chinanokayun.cn

Latest round

Angel

Last raised

Mar 2026

Total raised

Undisclosed

Investors

2

About Nokayun

Based in China, Nokayun is a high-end intelligent manufacturing company dedicated to building a full-spectrum flow cytometry platform covering analysis and sorting, and promoting the localization of high-end full-spectrum flow cytometry technology. It provides researchers in cell biology, immunology, and translational medicine with stable, reliable, high-performance, and intelligent flow cytometry solutions to support scientific research and clinical translation.

Who invested in Nokayun

2 investors across 1 round

See all investors in Nokayun

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Mar 30, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about Nokayun

Who invested in Nokayun?

Nokayun has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Nokayun raised?

Nokayun has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Nokayun last raise money?

Nokayun's most recent round on record is a Angel, in Mar 2026.

What does Nokayun do?

Based in China, Nokayun is a high-end intelligent manufacturing company dedicated to building a full-spectrum flow cytometry platform covering analysis and sorting, and promoting the localization of high-end full-spectrum flow cytometry technology.

Where is Nokayun headquartered?

Nokayun is headquartered in Shanghai, China.

Which VCs invest in companies like Nokayun?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, MPCi, Zijin Venture Capital and Legend Capital back healthcare companies at Nokayun's stage. Their profiles are linked below.

Raising like Nokayun? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.